Quarterly report pursuant to Section 13 or 15(d)

Restatement of Condensed Consolidated Financial Statements - Schedule of the effect of restatement to the Company's financial statements (Details)

v3.22.1
Restatement of Condensed Consolidated Financial Statements - Schedule of the effect of restatement to the Company's financial statements (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Oct. 31, 2021
Oct. 31, 2020
Oct. 31, 2021
Oct. 31, 2020
Jul. 31, 2021
Jan. 31, 2021
Jul. 31, 2020
Jan. 31, 2020
Current assets                
Accounts receivable $ 4,675   $ 4,675     $ 1,643    
Unbilled receivable 5,064   5,064     1,425    
Related party receivables and loan receivables 4,092   4,092     3,599    
Account and loan receivables 13,831   13,831     6,667    
Total current assets 97,878   97,878     45,667    
Total assets 106,181   106,181     51,691    
Current liabilities:                
Deferred revenue 16,379   16,379     12,481    
Total current liabilities 27,933   27,933     21,392    
Deferred revenue 17,910   17,910     21,563    
Total liabilities 47,383   47,383     46,665    
Stockholders' equity                
Additional paid-in capital 429,176   429,176     180,853    
Accumulated deficit (370,655)   (370,655)     (175,039)    
Total liabilities and stockholders' equity 106,181   106,181     51,691    
Operating expenses                
Research and development 24,455 $ 5,687 38,917 $ 19,965        
Sales and marketing 51,244 7,155 66,095 23,265        
General and administrative 79,735 4,715 91,419 16,690        
Operating Expenses 155,434 17,557 196,431 59,920        
Operating Loss (150,889) (12,613) (183,188) (43,224)        
Loss before income taxes (162,915) (12,435) (195,560) (43,099)        
Benefit (provision) for income taxes 34 19 56 58        
Net loss $ (162,949) $ (12,454) $ (195,616) $ (43,157)        
Basic and diluted net loss per common share $ (1.87) $ (0.19) $ (2.64) $ (0.67)        
Cash flows from operating activities                
Employee stock based compensation     $ 129,983 $ 27        
Changes in operating assets and liabilities:                
Accounts receivable     7,163 962        
Deferred revenue     (245) 2,689        
Net cash used in operating activities     (59,095) (39,897)        
Comprehensive loss $ (162,646) $ (12,905) (195,388) (43,559)        
Stock-based compensation 129,956 (29) 129,983 27        
Balance 58,798 3,664 58,798 3,664 $ (27,101) 5,026 $ 14,104 $ 3,069
As Previously Reported                
Current assets                
Accounts receivable 2,246   2,246          
Unbilled receivable 3,885   3,885          
Related party receivables and loan receivables 3,521   3,521          
Account and loan receivables 9,652   9,652          
Total current assets 93,699   93,699          
Total assets 102,002   102,002          
Current liabilities:                
Deferred revenue 12,929   12,929          
Total current liabilities 24,483   24,483          
Deferred revenue 17,181   17,181          
Total liabilities 43,204   43,204          
Stockholders' equity                
Additional paid-in capital 459,349   459,349          
Accumulated deficit (400,828)   (400,828)          
Total liabilities and stockholders' equity 102,002   102,002          
Operating expenses                
Research and development 28,144   42,606          
Sales and marketing 57,196   72,046          
General and administrative 100,267   111,952          
Operating Expenses 185,607   226,604          
Operating Loss (181,062)   (213,361)          
Loss before income taxes (193,088)   (225,733)          
Benefit (provision) for income taxes 34   56          
Net loss $ (193,122)   $ (225,789)          
Basic and diluted net loss per common share $ (2.22)   $ (3.05)          
Cash flows from operating activities                
Employee stock based compensation     $ 160,156          
Changes in operating assets and liabilities:                
Accounts receivable     2,984          
Deferred revenue     (3,934)          
Net cash used in operating activities     (59,095)          
Comprehensive loss $ (192,819)   (225,561)          
Stock-based compensation 160,129   160,156          
Balance 58,798   58,798          
Adjustments                
Current assets                
Accounts receivable 2,429   2,429          
Unbilled receivable 1,179   1,179          
Related party receivables and loan receivables 571   571          
Account and loan receivables 4,179   4,179          
Total current assets 4,179   4,179          
Total assets 4,179   4,179          
Current liabilities:                
Deferred revenue 3,450   3,450          
Total current liabilities 3,450   3,450          
Deferred revenue 729   729          
Total liabilities 4,179   4,179          
Stockholders' equity                
Additional paid-in capital (30,173)   (30,173)          
Accumulated deficit 30,173   30,173          
Total liabilities and stockholders' equity 4,179   4,179          
Operating expenses                
Research and development (3,689)   (3,689)          
Sales and marketing (5,952)   (5,951)          
General and administrative (20,532)   (20,533)          
Operating Expenses (30,173)   (30,173)          
Operating Loss 30,173   30,173          
Loss before income taxes 30,173   30,173          
Benefit (provision) for income taxes 0   0          
Net loss $ 30,173   $ 30,173          
Basic and diluted net loss per common share $ 0.35   $ 0.41          
Cash flows from operating activities                
Employee stock based compensation     $ (30,173)          
Changes in operating assets and liabilities:                
Accounts receivable     4,179          
Deferred revenue     4,179          
Comprehensive loss $ 30,173   30,173          
Stock-based compensation (30,173)   (30,173)          
As Restated                
Current assets                
Accounts receivable 4,675   4,675          
Unbilled receivable 5,064   5,064          
Related party receivables and loan receivables 4,092   4,092          
Account and loan receivables 13,831   13,831          
Total current assets 97,878   97,878          
Total assets 106,181   106,181          
Current liabilities:                
Deferred revenue 16,379   16,379          
Total current liabilities 27,933   27,933          
Deferred revenue 17,910   17,910          
Total liabilities 47,383   47,383          
Stockholders' equity                
Additional paid-in capital 429,176   429,176          
Accumulated deficit (370,655)   (370,655)          
Total liabilities and stockholders' equity 106,181   106,181          
Operating expenses                
Research and development 24,455   38,917          
Sales and marketing 51,244   66,095          
General and administrative 79,735   91,419          
Operating Expenses 155,434   196,432          
Operating Loss (150,889)   (183,188)          
Loss before income taxes (162,915)   (195,560)          
Benefit (provision) for income taxes 34   56          
Net loss $ (162,949)   $ (195,616)          
Basic and diluted net loss per common share $ (1.87)   $ (2.64)          
Cash flows from operating activities                
Employee stock based compensation     $ 129,983          
Changes in operating assets and liabilities:                
Accounts receivable     7,163          
Deferred revenue     (245)          
Net cash used in operating activities     (59,095)          
Comprehensive loss $ (162,646)   (195,388)          
Stock-based compensation 129,956              
Balance 58,798   58,798          
Additional Paid-in Capital [Member]                
Changes in operating assets and liabilities:                
Stock-based compensation 129,956 (29) 129,983 27        
Balance 429,176 167,353 429,176 167,353 181,181 180,853 164,929 $ 123,235
Additional Paid-in Capital [Member] | As Previously Reported                
Changes in operating assets and liabilities:                
Stock-based compensation 160,129   160,156          
Balance 459,349   459,349          
Additional Paid-in Capital [Member] | Adjustments                
Changes in operating assets and liabilities:                
Stock-based compensation (30,173)   (30,173)          
Balance (30,173)   (30,173)          
Additional Paid-in Capital [Member] | As Restated                
Changes in operating assets and liabilities:                
Stock-based compensation 129,956   129,983          
Balance 429,176   429,176          
Retained Earnings [Member]                
Changes in operating assets and liabilities:                
Balance (370,655) $ (162,823) (370,655) $ (162,823) $ (207,706) $ (175,039) $ (150,369)  
Retained Earnings [Member] | As Previously Reported                
Operating expenses                
Net loss (193,122)   (225,789)          
Changes in operating assets and liabilities:                
Balance (400,828)   (400,828)          
Retained Earnings [Member] | Adjustments                
Operating expenses                
Net loss 30,173   30,173          
Changes in operating assets and liabilities:                
Balance 30,173   30,173          
Retained Earnings [Member] | As Restated                
Operating expenses                
Net loss (162,949)   (195,616)          
Changes in operating assets and liabilities:                
Balance $ (370,655)   $ (370,655)